Inhibitor screening for volume-sensitive LRRC8A chloride channel

Area of Science:

• Biochemistry
• Computational Biology
• Pharmacology

Background:

• Leucine-rich repeat-containing protein 8A (LRRC8A) is crucial for volume-regulated anion channels and cellular volume homeostasis.
• Dysregulation of LRRC8A is implicated in diseases such as osteoarthritis.
• Targeting LRRC8A function offers a therapeutic strategy for associated pathologies.

Purpose of the Study:

• To virtually screen for potential small molecule inhibitors of LRRC8A.
• To evaluate the stability and binding affinity of identified compounds using molecular dynamics simulations.
• To lay the groundwork for developing novel osteoarthritis therapeutics targeting LRRC8A.

Main Methods:

• Virtual screening using molecular docking against the ZINC15 database.
• Identification of lead compounds based on Autodock Vina scores and druggability predictions.
• Molecular dynamics (MD) simulations to assess protein-ligand complex stability (RMSD, RMSF, RoG).
• MM/PBSA calculations for binding free energy estimation.

Main Results:

• A specific compound (ZINC000018195627) was identified with a high docking score of -8.8 Kcal/mol.
• MD simulations confirmed the stability of the LRRC8A-ligand complex.
• MM/PBSA analysis provided insights into the binding free energy, supporting the compound's inhibitory potential.

Conclusions:

• The study successfully identified and validated a potential LRRC8A inhibitor through computational methods.
• The findings provide a strong foundation for further preclinical development of LRRC8A-modulating osteoarthritis therapies.
• This research highlights the utility of virtual screening and MD simulations in drug discovery.